Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
about
Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation?Bibliometric analysis of literature on antifungal triazole resistance: 1980 - 2015.Untargeted antifungal therapy in adult patients with complicated intra-abdominal infection: protocol for a systematic review with meta-analysis.Persistent spontaneous fungal peritonitis secondary to Candida albicans in a patient with alcoholic cirrhosis and review of the literature.Dying with or Because of Invasive Fungal Infection? The Role of Immunity Exhaustion on Patient Outcome.Antifungal Treatment Strategies in the ICU: Beyond Meta-analysis.Should we Administer Antifungal Drugs Before the Diagnosis of Invasive Fungal Infection in Non-Neutropenic Critically Ill Patients?Lessons from uncertainty on antifungal treatment in ICU.Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?Antifungal use in intensive care units: another uncertainty that highlights the need for precision medicine.Is it time to combine untargeted antifungal strategies to reach the goal of 'early' effective treatment?The EMPIRICUS trial-the final nail in the coffin of empirical antifungal therapy in the intensive care unit?Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?From bedside to bench: the missing brick for patients with fungal sepsis.The paradox of the evidence about invasive fungal infection prevention.What Healthcare Workers Should Know about Environmental Bacterial Contamination in the Intensive Care Unit.Untargeted antifungal therapy in adult patients with complicated intra-abdominal infection: a systematic review.What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.Epidemiology, clinical characteristics, resistance, and treatment of infections by
P2860
Q37551817-D09C3724-75EA-48C3-BF3E-20E7589B9065Q37696920-99042F24-F7C8-4F02-9790-BAE543006C57Q38758069-7A523C43-2EDF-4C62-BC03-8D3160AD44F1Q39016489-6D1B329C-7594-473D-BAFB-56419E3CB12EQ40383367-642D120F-A901-438D-9716-335DE09DD835Q40383373-ED173108-B9E8-491F-AF79-F36E77504F89Q40383385-C6ACA189-8BB2-4FA9-95CF-830E79B2E24EQ42148479-92A90B6D-39D1-4158-8D83-0B0F07A94E01Q42177820-48B922A0-33A7-45E0-9CFA-3A335DC86637Q42331417-61C45874-BFEB-4DF6-B613-668325A05A07Q42358748-3F62BED5-1E89-4C48-8395-3D9ED55F101CQ42362382-6C8D0A28-59C2-4DD4-9469-D49313180DF1Q42378051-485DAC1F-904C-4849-881A-365756DD9A52Q42587933-244744A6-DB3E-4149-805E-A01809ECFAAFQ42854908-5D4550A2-E5DF-492D-AFE9-76AF31710AD4Q46246373-136017B0-63EC-47DC-BEB4-BFB60436B36FQ47619531-D8696220-3064-431B-AA72-1AAB7FDD6103Q47749829-F90FDB23-CC77-4B44-932A-DAFDD92275DBQ49379463-73EC3026-DEA1-4A5A-8AB8-EA6A604AE9C2Q58598193-0931C27A-833A-4230-9982-26D8244FA878
P2860
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Antifungal agents for preventi ...... openic critically ill patients
@ast
Antifungal agents for preventi ...... openic critically ill patients
@en
Antifungal agents for preventi ...... openic critically ill patients
@nl
type
label
Antifungal agents for preventi ...... openic critically ill patients
@ast
Antifungal agents for preventi ...... openic critically ill patients
@en
Antifungal agents for preventi ...... openic critically ill patients
@nl
prefLabel
Antifungal agents for preventi ...... openic critically ill patients
@ast
Antifungal agents for preventi ...... openic critically ill patients
@en
Antifungal agents for preventi ...... openic critically ill patients
@nl
P2093
P2860
P3181
P1476
Antifungal agents for preventi ...... openic critically ill patients
@en
P2093
Alessandra Maggiore
Alessandro R Naro
Antonino Giarratano
Massimo Attanasio
Santi Maurizio Raineri
P2860
P304
P3181
P356
10.1002/14651858.CD004920.PUB3
P577
2016-01-16T00:00:00Z